Global Emerging and Persistent Infectious Diseases (GEPID) - U.S.

The ISGP developed this book from the position papers, debates, and caucuses at the Global Emerging and Persistent Infectious Disease (GEPID) – U.S. conference convened on March 11-13, 2024 at the Johns Hopkins Bloomberg Center, Washington, D.C. by the ISGP in cooperation with the Bloomberg School of Public Health, School of Advanced International Studies, and the Science Diplomacy Hub at Johns Hopkins University, the University of Maryland School of Medicine, the ISGP Board of Directors, and the Global Advisory Panel. 

Presenters/Authors:

• Dr. Arturo Casadevall, Chair, W. Harry Feinstone Department of Molecular Microbiology & Immunology and Infectious Diseases, Johns Hopkins Bloomberg School of Public Health
• Dame Sally C. Davies, U.K. Special Envoy on Antimicrobial Resistance
• Dr. Amy Wesolowski, Associate Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health
• Dr. Kent E. Kester, Vice President, Translational Medicine, International AIDS Vaccine Initiative, and
• Dr. Jerome Kim, Director General, International Vaccine Institute
• Dr. Rebecca Katz, Director and Professor, Center for Global Health Science and Security
• Dr. Michele P. Andrasik, Principal Staff Scientist, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center